A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine

Summary

The purpose of this study is to investigate the safety, tolerability and immunogenicity of ascending doses of a novel, universal flu vaccine, in healthy volunteers.

Timeline

Start

2010-08

Primary completion

2011-03

Completion

2011-08

Publications

• Francis JN, Bunce CJ, Horlock C, Watson JM, Warrington SJ, Georges B, Brown CB. A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety. Vaccine. 2015 Jan 3;33(2):396-402. doi: 10.1016/j.vaccine.2014.06.006. Epub 2014 Jun 10.

Drugs

Indications